Glioblastoma Multiforme

Radiologic-Pathologic Correlation

Abstract Introduction Clinical Presentation Historical Perspective

Etiology and Genetics Pathologic Characteristics Radiologic-Pathologic Correlation

Therapy and Prognosis Conclusions Source Information References

References

1. Bondy ML, Wrensch M. Update on brain cancer epidemiology. Bull Cancer 1993; 45:365-369.
Return to: Introduction

2. Bruner JM. Neuropathology of malignant gliomas. Semin Oncol 1994; 21:126-138.
Return to: Introduction

3. Boring CC, Squires TS, Tong T. Cancer statistics. CA 1993; 43:7-26.
Return to: Introduction

4. Desmeules M, Mikkelsen T, Mao Y. Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst 1992; 84:442-445.
Return to: Introduction

5. Mao Y, Desmeules M, Semenciw RM, et al. Increasing brain cancer rates in Canada. Can Med Assoc J 1991; 145:1583-1591.
Return to: Clinical Presentation

6. Etude epidemilogique des tumeurs primitives du neuraxe dans le region Rhone-Alpes. Rev Neurol 1975; 131:691-708.
Return to: Clinical Presentation

7. Radhakrishnan K, Bohnen NI, Kurland LT. Epidemiology of brain tumors. In: Morantz RA, Walsh JW, eds. Brain tumors. New York, NY: Dekker, 1994; 1-19.
Return to: Clinical Presentation

8. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985; 35:219-226.
Return to: Clinical Presentation

9. Medical Research Council Brain Tumor Working Party. Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neurooncol 1990; 9:47-55.
Return to: Clinical Presentation

10. Vertosick FT, Selker RG. Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery 1990; 27:516-522.
Return to: Clinical Presentation

11. Bailey P, Cushing H. A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. Philadelphia, Pa: Lippincott, 1926; 95.
Return to: Historical Perspective

12. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3:255-268.
Return to: Historical Perspective

13. Steck PA, Bruner JM, Pershouse MA, et al. Molecular, genetic, and biologic aspects of primary brain tumors. Cancer Bull 1993; 45:296-303.
Return to: Historical Perspective

14. Debiec-Richter M, Liberski PP. Molecular changes involved in the carcinogenesis of brain tumors. Folia Neuropathol 1994; 32:199-203.
Return to: Historical Perspective

15. Louis DN, Seizinger BR. Genetic basis of neurological tumours. Baillieres Clin Neurol 1994; 3:335-352.
Return to: Historical Perspective

16. Watanabe K, Tachibana O, Sato K, et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996; 6:217-224.
Return to: Historical Perspective | Etiology and Genetics

17. Turcot J, Despres JP, St Pierre F. Malignant tumors of the CNS associated with familial polyposis of the colon: a report of two cases. Dis Colon Rectum 1959; 2:465-468.
Return to: Etiology and Genetics

18. Bodmer WF, Bailey CJ, Eliss A, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614-616.
Return to: Etiology and Genetics

19. Sorenson SA, Mulvihill JJ, Nielson A, et al. Long-term followup of von Recklinghausen neurofibromatosis: survival and malignant neoplasms. N Engl J Med 1986; 314:1010-1015.
Return to: Etiology and Genetics

20. Srivastava S, Zou Z, Pirollo K, et al. Germ-line transmission of a mutated p53 gene in a cancer prone family with Li-Fraumeni syndrome. Nature 1991; 348:747-749.
Return to: Etiology and Genetics

21. Posner JB. Section VI: neoplastic disorders. In: Scientific American Medicine, section 11, neurology. New York, NY: Scientific American, 1995.
Return to: Etiology and Genetics

22. Wu JK, Ye Z, Darras BT. Frequency of p53 tumor suppressor gene mutations in human primary brain tumors. Neurosurgery 1993; 33: 824-830.
Return to: Etiology and Genetics

23. Haapasalo H, Isola J, Sallinen P, et al. Aberrant p53 expression in astrocytic neoplasms of the brain: association with proliferation. Am J Pathol 1993; 142:1347-1351.
Return to: Etiology and Genetics

24. Van Meir EG, Roemer K, Diserens AC, et al. Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells. Proc Natl Acad Sci 1995; 92:1008-1012.
Return to: Etiology and Genetics

25. Thapar K, Fukuyama K, Rutka JT. Neurogenetics and the molecular biology of human brain tumors. In: Kaye AH, Laws ER, eds. Brain tumors. New York, NY: Churchill Livingstone 1995; 69-97.
Return to: Etiology and Genetics

26. Westermark B, Nister M. Molecular genetics of human glioma. Curr Opin Oncol 1995; 7: 220-225.
Return to: Etiology and Genetics

27. Rasheed BK, Fuller GN, Friedman AH, et al. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromosom Cancer 1992; 5: 75-82.
Return to: Etiology and Genetics

28. Farwell J, Flannery JJ. Second primaries in children with central nervous system tumors. J Neurooncol 1984; 54:135-138.
Return to: Etiology and Genetics

29. Ron E, Modan B, Boice JD, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319: 1033-1039.
Return to: Etiology and Genetics

30. Fontana M, Stanton C, Pompili A, et al. Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia. Cancer 1987; 60:1510-1518.
Return to: Etiology and Genetics

31. Kernohan JW, Sayre GP. Tumors of the central nervous system. In: Atlas of tumor pathology, fasc 35. Washington, DC: Armed Forces Institute of Pathology, 1952.
Return to: Pathologic Characteristics

32. Kleihues P, Burger PC, Scheithauer BW, et al. Histological typing of tumours of the central nervous system. 2nd ed. Berlin, Germany: Springer, 1993.
Return to: Pathologic Characteristics

33. Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor and glioma angiogenesis. Int J Cancer 1994; 59:520-529.
Return to: Pathologic Characteristics

34. Van Meir EG, Polverini PJ, Chazin VR, et al. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet 1994; 8:171-176.
Return to: Pathologic Characteristics

35. Ariza A, Fernandez LA, Inagami T, et al. Renin in glioblastoma multiforme and its role in neovascularization. Am J Clin Pathol 1988; 90:437-441.
Return to: Pathologic Characteristics

36. Zimmerman RA. Imaging of adult central nervous system primary malignant gliomas. Cancer 1991; 67:1278-1283.
Return to: Pathologic Characteristics

37. Di Chiro G, Brooks RA. PET-FDG of treated and untreated cerebral gliomas. J Nucl Med 1988; 29:421-422.
Return to: Radiologic-Pathologic Correlation

38. Byrne TN. Imaging of gliomas. Semin Oncol 1994; 21:162-171.
Return to: Radiologic-Pathologic Correlation

39. Valk P, Budinger T, Levin V, et al. PET of malignant cerebral tumors after brachytherapy. J Neurosurg 1988; 69:830-838.
Return to: Radiologic-Pathologic Correlation | Therapy and Prognosis

40. Bailey P, Cushing H. Cited by: Rubenstein LJ. Tumors of the central nervous system. In: Atlas of tumor pathology, fasc 6, ser 2. Washington, DC: Armed Forces Institute of Pathology, 1972; 13.
Return to: Radiologic-Pathologic Correlation

41. Giordana MT, Bradac GB, Pagni CA, et al. Primary diffuse leptomeningeal gliomatosis with anaplastic features. Acta Neurochir 1995; 132: 154-159.
Return to: Radiologic-Pathologic Correlation

42. Salcman M. Survival in glioblastoma: historical perspective. Neurosurgery 1980; 7:435-439.
Return to: Therapy and Prognosis

43. Mineta T, Rabkin SD, Yazaki T, et al. Attenuated multi-mutated HSV-1 for the treatment of malignant gliomas. Nature Med 1995; 1:938-943.
Return to: Therapy and Prognosis

44. Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer with interleukin-2. N Engl J Med 1987; 316:889-897.
Return to: Therapy and Prognosis

Abstract Introduction Clinical Presentation Historical Perspective

Etiology and Genetics Pathologic Characteristics Radiologic-Pathologic Correlation

Therapy and Prognosis Conclusions Source Information References